Article Text

Download PDFPDF
Impact of injecting drug use on the interruption of antiretroviral therapies
  1. R Muga,
  2. J M Egea,
  3. A Sanvisens,
  4. J Arnal,
  5. C Tural,
  6. J Tor,
  7. C Rey-Joly
  1. Servicio de Medicina Interna, 4a planta, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
  1. Correspondence to:
 Dr R Muga
 Hospital Universitari Germans Trias i Pujol, Servicio de Medicina Interna, 4a planta, Hospital Universitari Germans Trias i Pujol, Ctra. canyet s/n, 08916 Badalona, Spain;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

It has been pointed out that HIV positive patients with a history of drug misuse are less likely to undergo antiretroviral therapy (ART) than those who belong to other categories of transmission.1,2 Moreover, inadequate use of ART in injecting drug users (IDUs) is controversial because of the risk of parenteral and/or sexual transmission of drug resistant HIV variants.3

The aim of this study was to describe the frequency of use and cessation of antiretroviral regimens over a period characterised by the introduction of highly active antiretroviral therapy (HAART) in Spain.



Cross sectional study in HIV positive intravenous heroin misusers consecutively referred to detoxification in a tertiary hospital in metropolitan Barcelona between April 1997 and March 2000. Questionnaires on the characteristics of injecting drug use …

View Full Text


  • Funding: this work was partially supported by grant Fondo de Investigación Sanitaria (FIS), Ministry of Health, Spain (grants 00/0294 and C03/005) and Fundació La Marató de TV3 (grant 02/1330).

  • Conflicts of interest: none declared.

Linked Articles

  • In this issue
    C Alvarez-Dardet J R Ashton